Pop Culture Group fields shareholder questions ahead of extraordinary meeting
Bitget2026/10/09 21:01Pop Culture Group set an Oct. 22, 2026 extraordinary meeting to seek approval to migrate its domicile from the Cayman Islands to the BVI. Only holders of Class A and Class B ordinary shares on the Oct. 5, 2026 record date can vote. Class A carries one vote per share; Class B carries 100 votes per share; 1,637,443 Class A shares, 70,510 Class B shares outstanding. Migration proposal needs a two-thirds majority of votes cast; adjournment proposal needs a simple majority of votes cast. Shareholders do not have appraisal rights for the matters to be voted on at the meeting. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pop Culture Group Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-108556), on October 09, 2026, and is solely responsible for the information contained therein.
- Pop Culture Group set an Oct. 22, 2026 extraordinary meeting to seek approval to migrate its domicile from the Cayman Islands to the BVI.
- Only holders of Class A and Class B ordinary shares on the Oct. 5, 2026 record date can vote.
- Class A carries one vote per share; Class B carries 100 votes per share; 1,637,443 Class A shares, 70,510 Class B shares outstanding.
- Migration proposal needs a two-thirds majority of votes cast; adjournment proposal needs a simple majority of votes cast.
- Shareholders do not have appraisal rights for the matters to be voted on at the meeting.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Wedbush lowers the target price for Cerebras Systems to $190.
BUZZ-Zura Bio shares plummet after mid-stage trial failure of skin disease drug

Netcapital Gets Nasdaq Extension Until Feb. 9 to File Overdue Reports
